Home » Topics » BioWorld Science

BioWorld Science
RSS

First clinical results for CVS-1123

April 19, 1996

SD-998, thrombin inhibitor

April 19, 1996

New series of thrombin inhibitors claimed by Thomae

April 19, 1996

Yamanouchi selects YM-471 for clinical development

April 19, 1996

Corvert now available in U.S.

April 19, 1996

Posicor submitted for approval

April 19, 1996

New ETA antagonist from SmithKline Beecham: SB-225757

April 19, 1996

EMD-94246, promising endothelin antagonist for hypertension

April 19, 1996

Zanidip approved for marketing in U.K.

April 19, 1996

SKB discloses NK3 antagonists in patent literature

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...